Please assess the completion status of the following clinical trial:

Trial Title: Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled for unilateral cataract surgery (phacoemulsification or extracapsular extraction) with posterior chamber intraocular lens implantation on the day prior to study enrollment~* Meet the best corrected visual acuity score requirement~* Meet the IOP requirement~* Additional inclusion criteria also apply~Exclusion Criteria:~* Known hypersensitivity or poor tolerance to bromfenac sodium or any component of the study medications or any of the procedural medications~* Use of any ocular topical, or systemic medication that could interfere with normal lacrimation, wound healing, the test agent, or the interpretation of study results, within 1 week prior to Day of Surgery~* Additional exclusion criteria also apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ISV-303 BID (Type: EXPERIMENTAL): None
- ISV-303 QD (Type: EXPERIMENTAL): None
- Xibrom BID (Type: ACTIVE_COMPARATOR): None
- DuraSite Vehicle BID (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).